Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lisa, Rook"'
Publikováno v:
Gastrointestinal Nursing. 18:16-19
This article aims to inform how specialist inflammatory bowel disease (IBD) nurses can protect IBD patients through the novel coronavirus (COVID-19) pandemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0638434c75af717f5311560d720f678
https://doi.org/10.12968/gasn.2020.18.4.16
https://doi.org/10.12968/gasn.2020.18.4.16
Autor:
Anne Phillips, Prashant Kant, Gerry Robins, James Turvill, Maxine Rawle, Simon Smale, Lisa Rook
Publikováno v:
Frontline Gastroenterology. 8:183-188
We have previously published an evidence-based care pathway for the use of faecal calprotectin (FC) to monitor patients with Crohn's disease established on therapy. Patients are treated as low, intermediate or high risk of continuing Crohn's disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85531b6aeee41a41633e6fadcf6e3bd3
https://doi.org/10.1136/flgastro-2016-100780
https://doi.org/10.1136/flgastro-2016-100780
Publikováno v:
Gastroenterology Nursing
There has been a growing interest in a patient-centered model of care in inflammatory bowel disease; however, no relevant study using a mixed methodology has been conducted to date. Thus, our multidisciplinary group aimed to explore the issue of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c752f72931bced232f6494d693dc1113
https://pubmed.ncbi.nlm.nih.gov/28002076
https://pubmed.ncbi.nlm.nih.gov/28002076
Publikováno v:
Gut. 64:A197.2-A198
Introduction Long term follow up is required for patients with inflammatory bowel disease (IBD). In line with the IBD Standards,1an important element of providing a quality service to IBD patients is that mechanisms are in place to ‘obtain and resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35537b57e35ffb4ef2ddf955587a8f8
https://doi.org/10.1136/gutjnl-2015-309861.424
https://doi.org/10.1136/gutjnl-2015-309861.424
Publikováno v:
Gut. 64:A231.2-A232
Introduction From January 2014 the Department of Gastroenterology at York Hospital introduced evidence based guidelines for the use of faecal calprotectin (FC) in monitoring patients with Crohn’s disease (CD) established on a management plan. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c9650c65e943895256a2950ae1504c3
https://doi.org/10.1136/gutjnl-2015-309861.495
https://doi.org/10.1136/gutjnl-2015-309861.495
Autor:
Mikocka-Walus A; Antonina Mikocka-Walus, PhD, is Senior Lecturer, Department of Health Sciences, University of York, Heslington, York, United Kingdom. Madeleine Power, MSc, is Research Assistant, Department of Health Sciences, University of York, Heslington, York, United Kingdom. Lisa Rook, RN, is IBD Nurse, IBD Service, Department of Gastroenterology, York Teaching Hospital, York, United Kingdom. Gerry Robins, MD, is Consultant Gastroenterologist, IBD Service, Department of Gastroenterology, York Teaching Hospital, York, United Kingdom. CCUK York Walk Planning Committee, The Crohn's and Colitis UK York Walk Planning Committee, York, United Kingdom., Power M, Rook L, Robins G
Publikováno v:
Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates [Gastroenterol Nurs] 2018 Jan/Feb; Vol. 41 (1), pp. 59-64.